XDNA - Kelly CRISPR & Gene Editing Technology ETF (USD) (US48817R7061)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Alle auswählen Alle zurücksetzen

Speichern Schließen

ETF & Funds ceased circulation

(%)

US48817R7061

XDNA ISIN

Exchange Traded Funds (ETF)

Fondstyp

Kelly

Anbieter

NAV pro Aktie

12/01/2022

Startdatum

1 Wiederholungen pro Jahr

Ausschüttung von Dividenden

CEOJLS

CFI

XDNA

Ticker

Closed

Status

Equity

Investitionsobjekt

Healthcare

Sektor

Global

Geographie

Strategic CRISPR & Gene Editing Technology Index

Benchmark

0.78 %

Gesamtkostenquote

Physical

Replikationsmethode

Nein

UCITS

Letzte Daten zum

Zum Vergleichen hinzufügen

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

Bond-Screener
Watchlist
Excel-Add-In

Zugang erhalten

Kurs-Dynamik

Fund profile

The Kelly CRISPR & Gene Editing Technology ETF seeks to replicate the price and yield performance of the Strategic CRISPR & Gene Editing Technology Index investing in a concentrated portfolio of companies that engage in CRISPR & gene editing technology activities

XDNA profile

The Kelly CRISPR & Gene Editing Technology ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The Kelly fund’s base currency is USD and the share class was registered 12.01.2022 with unique ISIN - US48817R7061. Main exchange is NASDAQ and ticker symbol is XDNA. The total expense ratio is 0.78%. The Kelly CRISPR & Gene Editing Technology ETF (USD) pays dividends 1 time(s) per year.

XDNA - Kelly CRISPR & Gene Editing Technology ETF (USD) (US48817R7061)

Kurs-Dynamik

Fund profile

XDNA profile

Einkommens-Zahlung (US48817R7061)

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds